Phase 3 trial in China successfully confirms ACARIZAX® safety and efficacy in patients with house dust mite allergy

Phase 3 trial in China confirms ACARIZAX® safety and efficacy in house dust mite allergy patients

Posted by GlobeNewswire by notified on October 19, 2026

-------- Original Version -----------

19110819Phase 3 trial in China successfully confirms ACARIZAX® safety and efficacy in patients with house dust mite allergy

-------- English Version ------------

Phase 3 trial in China successfully confirms ACARIZAX® safety and efficacy in patients with house dust mite allergy

-------- Link if available ----------

No Link available